Medi Caps Intrinsic Value
Medi Caps (MEDICAPQ) median intrinsic value is ₹62.46 from 9 valuation models (range ₹36–₹78), vs current price ₹25.93 — +140.9% upside (Trading Below Calculated Value), margin of safety 58.5%. Read MEDICAPQ dividend yield for the complete payout history and dividend yield track record.
MEDICAPQ Valuation Methods Summary — DCF, Graham Number & P/E
Medi Caps intrinsic value across 9 models vs current price ₹25.93 — upside/downside and value range per method. For current market price and key ratios, visit Medi Caps stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹77.79 | ₹62.23 - ₹93.35 | +200.0% | EPS: ₹9.76, Sector P/E: 22x |
| Book Value Method | asset | ₹64.83 | ₹58.35 - ₹71.31 | +150.0% | Book Value/Share: ₹86.15, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹51.86 | ₹46.67 - ₹57.05 | +100.0% | Revenue/Share: ₹27.69, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹51.86 | ₹46.67 - ₹57.05 | +100.0% | EBITDA: ₹16.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹35.71 | ₹28.57 - ₹42.85 | +37.7% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹62.46 | ₹56.21 - ₹68.71 | +140.9% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹77.79 | ₹70.01 - ₹85.57 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹51.86 | ₹46.67 - ₹57.05 | +100.0% | ROE: 10.7%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹77.79 | ₹70.01 - ₹85.57 | +200.0% | EPS: ₹9.76, BVPS: ₹86.15 |
MEDICAPQ Intrinsic Value vs Market Price — All Valuation Models
Medi Caps fair value range ₹36–₹78 vs current market price ₹25.93 across 9 valuation models. Analyse MEDICAPQ shareholder distribution to track promoter, FII and institutional holdings.
MEDICAPQ Intrinsic Value Analysis — Undervalued or Overvalued?
Medi Caps median intrinsic value ₹62.46, current price ₹25.93 — Trading Below Calculated Value by 140.9%, margin of safety 58.5%.
What is the intrinsic value of MEDICAPQ?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Medi Caps (MEDICAPQ) is ₹62.46 (median value). With the current market price of ₹25.93, this represents a +140.9% variance from our estimated fair value.
The valuation range spans from ₹35.71 to ₹77.79, indicating ₹35.71 - ₹77.79.
Is MEDICAPQ undervalued or overvalued?
Based on our multi-method analysis, Medi Caps (MEDICAPQ) appears to be trading below calculated value by approximately 140.9%.
MEDICAPQ Financial Health — Key Ratios vs Industry Benchmarks
Medi Caps financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 47.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 10.7% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | -61.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.31x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
MEDICAPQ Cash Flow Quality — Operating & Free Cash Flow
Medi Caps operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹7 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-6 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹7 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹15 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |